Europe Human Microbiome Market is growing with a CAGR of 19.9% by 2029

Microbiome is the genetic material of all the microbes - bacteria, fungi, protozoa and viruses - that live on and inside the human body. The number of genes in all the microbes in one person's microbiome is 200 times the number of genes in the human genome. The most widely used method of identification of microbiome analysis is 16s rRNA sequencing. Identification and understanding of these microbiotas have led to the application of these microorganisms in the betterment of human health via various products such as probiotics, prebiotics and other associated drugs.

Europe human microbiome market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyzes that the market is growing with a CAGR of 19.9% in the forecast period of 2022 to 2029 and is expected to reach USD 618.60 million by 2029.

Read more :
https://www.databridgemarketresearch.com/reports/europe-human-microbiome-market

Market Analysis and Insights

Microbiota means the microbial taxa associated with humans and microbiome means the catalog of these microbes and their genes. The aggregation of all the microbiota reside on or within human tissues and bio fluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract and others. The human microbiota consists of 10-100 trillion symbiotic microbial cells harbored by each person, primarily bacteria in the gut. The human microbiome consists of the genes these cells harbor.

Europe Human Microbiome Market Dynamics
Drivers

Increasing prevalence of lifestyle and chronic diseases

Due to global rise of chronic diseases, there is an increase in the demand for effective therapy products which will increase in upcoming years. Therefore, rising incidences are expected to act as a driver for the growth of the market.

Human microbiome therapeutic development for disease treatment

The microbiome contains billions of bacteria, some beneficial or particular to certain diseases. Nevertheless, in additive, subtractive, or modulatory therapy, microbiome therapy seeks to alter the gut microbiota by using natural or artificial bacteria, antibiotics and bacteriophages. The human gut microbiome plays an important role in improving the efficacy of compounds. The combination of microbes gives better results with specific diseases and the link between specific diseases and microbes provides a better opportunity for drug development. So, increase in the therapeutic development for disease treatment will help in the growth of the market.

Furthermore, improved technology advancement, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the market.

GET A PDF SAMPLE:

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-human-microbiome-market

Europe Human Microbiome Market Scope
Europe human microbiome market is segmented into product, application, technology, type, disease, end users and distributors. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

Probiotics
Prebiotics
Diagnostic Tests
Drugs
Supplements
Fecal Microbiota Transplant
Others
On the basis of product, the market is segmented into probiotics, prebiotics, diagnostic tests, drugs, supplements, fecal microbiota transplant and others.

Application

Therapeutic
Diagnostic
On the basis of application, the market is segmented into therapeutic and diagnostic.

Disease

Infectious Disease
Dermatological Disorders
Autoimmune Disorder
Metabolic Disorder
Gastrointestinal Disorders
Cancer
Mental Disorders
C. Difficile Infection
Primary Hyperoxyureasolution-Phase
Others
On the basis of disease, the market is segmented into infectious disease, dermatological disorders, autoimmune disorder, metabolic disorder, gastrointestinal disorders, cancer, mental disorders, C. difficile infection, primary hyperoxyureasolution-phase and others.

Technology

Genomics
Proteomics
Metabolomics
On the basis of technology, the market is segmented into genomics, proteomics and metabolomics.

Type

Small Molecule
Biologic
On the basis of type, the market is segmented into small molecule and biologic.

End User

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hypermarket/Supermarket
Clinics
Others
On the basis of end user, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, hypermarket/supermarket, clinics and others.

Distributor

Direct Tender
Retail Sales

More Links:
https://www.databridgemarketresearch.com/reports/global-neuroendocrine-tumors-market

https://www.databridgemarketresearch.com/reports/colombia-gastric-cancer-drugs-market

https://www.databridgemarketresearch.com/reports/europe-human-microbiome-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.